Thermo Fisher Scientific ... (TMO)

NYSE: TMO · Real-Time Price · USD

426.11

6.22 (1.48%)

At close: May 02, 2025, 1:44 PM

Thermo Fisher Scientific Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	4.01B	8.08B	8.52B	4.48B	10.32B	2.4B	2.1B	1.33B	786M
Short-Term Investments	1.56B	-1.97B	n/a	n/a	n/a	n/a	3M	10M	15.8M
Long-Term Investments	n/a	45M	154M	63M	53M	67M	64M	32M	37M
Other Long-Term Assets	4.49B	3.95B	-2.85B	4.35B	2.46B	1.85B	1.05B	-2.77B	-2.56B
Receivables	8.19B	9.66B	9.43B	8.95B	6.47B	4.95B	4.59B	3.88B	3.05B
Inventory	4.98B	5.09B	5.63B	5.05B	4.03B	3.37B	3B	2.97B	2.21B
Other Current Assets	3.4B	1.76B	1.64B	1.64B	1.13B	1.17B	922M	1.24B	973M
Total Current Assets	22.14B	24.59B	25.23B	20.11B	21.96B	11.89B	10.63B	9.42B	7.02B
Property-Plant & Equipment	9.31B	9.45B	10.87B	9.86B	6.69B	5.45B	4.17B	4.05B	2.58B
Goodwill & Intangibles	61.39B	60.69B	58.67B	62.07B	38.73B	39.73B	40.33B	41.97B	35.3B
Total Long-Term Assets	75.18B	74.14B	69.7B	72B	45.47B	45.24B	44.55B	46.05B	37.91B
Total Assets	97.32B	98.73B	97.15B	95.12B	69.05B	58.38B	56.23B	56.67B	45.91B
Account Payables	n/a	2.87B	3.38B	2.87B	2.17B	1.92B	1.61B	1.43B	926M
Deferred Revenue	n/a	2.69B	2.6B	2.65B	1.27B	916M	809M	719M	485.9M
Short-Term Debt	2.21B	3.6B	5.58B	2.54B	2.63B	676M	1.27B	2.13B	1.26B
Other Current Liabilities	11.12B	331M	n/a	n/a	-368M	n/a	n/a	n/a	1.49B
Total Current Liabilities	13.33B	14.01B	17.01B	13.44B	10.3B	6.2B	6.15B	7.05B	4.87B
Long-Term Debt	29.06B	31.31B	28.91B	32.15B	19.11B	17.08B	17.72B	18.87B	15.48B
Other Long-Term Liabilities	5.26B	4.64B	4.24B	4.72B	2.7B	2.67B	2.52B	2.57B	4.02B
Total Long-Term Liabilities	34.32B	37.87B	28.8B	32.15B	19.15B	17.09B	17.85B	19B	15.48B
Total Liabilities	47.65B	51.88B	53.01B	54.15B	34.53B	28.71B	28.65B	31.26B	24.37B
Total Debt	31.27B	34.92B	34.49B	34.87B	21.73B	17.75B	18.99B	21.01B	16.63B
Common Stock	444M	442M	441M	439M	437M	434M	432M	428M	415M
Retained Earnings	53.1B	47.36B	41.91B	35.43B	28.12B	22.09B	18.7B	15.91B	13.93B
Comprehensive Income	-2.7B	-3.22B	-3.1B	-2.33B	-2.81B	-2.68B	-2.5B	-2B	-2.64B
Shareholders Equity	49.55B	46.73B	43.98B	40.79B	34.51B	29.68B	27.59B	25.41B	21.54B
Total Investments	1.56B	-1.92B	154M	63M	53M	67M	64M	32M	37M